Istradefylline for Parkinson's Disease User Reviews

Brand names: Nourianz

Rating: 6.0

Istradefylline has an average rating of 6.0 out of 10 from a total of 3 reviews for the treatment of parkinson's disease. 67% of reviewers reported a positive experience, while 33% reported a negative experience.

10		0%
9		0%
8		67%
7		0%
6		0%
5		0%
4		0%
3		0%
2		33%
1		0%

Anonymous
Taken for less than 1 month
December 27, 2022

"A useful medication - if you can afford it. Being on Medicare means you are on a 'government' plan, and you will get no assistance from any program. So once again, retirees are screwed by the drug companies that 'offer' assistance programs."

2 / 10

Was this helpful?Yes No

4 Report

Par...
Taken for 6 months to 1 year
January 28, 2021

"Been taking Nourianz 20 mg for 8 months along with Rytary. Together, they have helped my rigidity. Have not experienced any side effects from either medication."

8 / 10

Was this helpful?Yes No

10 Report

Kel...
Taken for 1 to 2 years
February 26, 2024

"Good drug; had to stop taking it because of cost. Bummer, patent does not expire until 2027 - no competition."

8 / 10

Was this helpful?Yes No

1 Report

Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.